Jessica-stormlover
Diamond Member
- Oct 4, 2021
- 2,977
- 3,431
- 1,938
Wharton's jelly found to halt diabetes progression in Phase II trial
by Justin Jackson , Medical Xpress
Appears promising!
Wharton's jelly found to halt diabetes progression in Phase II trial
Research in Sweden led by the University of Uppsala has looked into using mesenchymal stromal cells to halt the progress of newly diagnosed type 1 diabetes. In the paper, "Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II...
medicalxpress.com
Research in Sweden led by the University of Uppsala has looked into using mesenchymal stromal cells to halt the progress of newly diagnosed type 1 diabetes. In the paper, "Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomized double-blind placebo-controlled trial," published in the journal Diabetologia, researchers detail the study and results of a small sample set of 24 participants.
The researchers used Wharton's jelly-derived mesenchymal stromal cells (MSCs) that were not derived from the patients in the study (allogeneic).
Appears promising!